Verified and dedicated negative control for nucleic acid testing (NAT) assays detecting single or multiple human respiratory pathogens.
Designed to validate and monitor human sample processing, extraction, amplification, and detection as an external run control.
Human sputum-like matrix containing A549 epithelial cells (20,000 cells/mL) from human lung carcinoma.
Pre-screened negative specimen, tested free of nucleic acids from a range of respiratory pathogens.
Lyophilized monodose presentation: reconstitute before use.
Non-infectious material.
Compatible with multiple molecular platforms.
MORE RESOURCES
The latest insights, news, and research articles from our scientific team.
Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Beyond detection: H. pylori testing in today’s laboratory workflow
Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...
Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...
